Michael Greiner - 06 Mar 2025 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
Interim CEO
Signature
/s/ Mojirade James, as attorney-in-fact for Michael C. Greiner
Issuer symbol
AVNS
Transactions as of
06 Mar 2025
Transactions value $
-$208,034
Form type
4
Filing time
10 Mar 2025, 11:51:06 UTC
Previous filing
06 Mar 2025
Next filing
11 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Tax liability -$78.2K -5.11K -2.51% $15.30 198K 06 Mar 2025 Direct F1
transaction AVNS Common Stock Tax liability -$130K -8.49K -4.28% $15.30 190K 06 Mar 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 11,424 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2025. Each TRSU is the economic equivalent of one share of Common Stock.
F2 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 18,965 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2024 and (ii) vested on March 6, 2025. Each TRSU is the economic equivalent of one share of Common Stock.